Global X Genomics and Biotechnology ETF (GNOM) |
| 42.06 -0.02 (-0.05%) 10-09 16:00 |
| Open: | 42.23 |
| High: | 42.42 |
| Low: | 42.0201 |
| Volume: | 18,189 |
| Market Cap: | 48(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 49.64 |
| Resistance 1: | 42.50 |
| Pivot price: | 39.38 |
| Support 1: | 38.48 |
| Support 2: | 36.00 |
| 52w High: | 44.52 |
| 52w Low: | 27.2 |
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 01 Oct 2025
These 3 Biotech ETFs Have Gone Viral, and They All Offer Traders a Cure - inkl
Mon, 18 Aug 2025
Global X Announces Five ETF Reverse Stock Splits - PR Newswire
Wed, 13 Aug 2025
7 Best Biotech ETFs to Buy Now - Money US News.com
Wed, 18 Jun 2025
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Sat, 20 Apr 2024
ETF Battles: ARKG Vs IDNA Vs GNOM - ETF.com
Sun, 28 May 2023
GNOM: A Genomics ETF That Will Have Its Day, Even If Not Right Now - Seeking Alpha
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
